Successful treatment of hodgkin lymphoma in nijmegen breakage syndrome

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 1, 2009, Pages 49-52

  Jovanovic, Ankica ^a   Minic, Predrag ^a   Scekic Guc, Marija ^a   Djuricic, Slavisa ^a   Cirkovic, Sanja ^a   Weemaes, Corry ^b   Pasic, Srdjan ^a  

^a Mother and Child Health Institute Belgrade rs   (Serbia)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hodgkin disease; Lymphoid malignancy; Nijmegen breakage syndrome

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT; COPP PROTOCOL; VBA PROTOCOL;

ANAMNESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG DOSE REDUCTION; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; MULTIPLE CYCLE TREATMENT; NIJMEGEN BREAKAGE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; NIJMEGEN BREAKAGE SYNDROME; PREDNISONE; PROCARBAZINE; REMISSION INDUCTION; VINBLASTINE; VINCRISTINE;

EID: 59449083656     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318190d72c     Document Type: Article

References (25)

1. Weemaes CMR, Hustinx TWJ, Scheres JMJC, et al. A new chromosomal instability disorder: Nijmegen breakage syndrome. Acta Paediatr Scand. 1981;70:557-564.
2. International Nijmegen breakage syndrome study group. Nijmegen breakage syndrome. Arch Dis Child. 2000;82: 400-406.
3. Varon R, Vissinga C, Platzer M, et al. Nibrin, a novel DNA double-break strand protein is mutated in Nijmegen breakage syndrome. Cell. 1998;93:467-476.
4. Wegner RD, German JJ, Chrzanowska H, et al. Chromosome instability syndromes other than ataxia telangiectasia. In: Ochs HD, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. Chapter 30. 2nd ed. Oxford University Press US, 2007:427-453.
5. Morrel D, Cromartie E, Swift M. Mortality and cancer incidence in 263 patients with ataxia telangiectasia. J Natl Cancer Inst. 1986;77:89-92.
6. Mueller BU, Pizzo PA. Cancer in children with primary immunodeficiency. J Pediatr. 1995;126:1-10.
7. Muller H. Recesively inherited deficiencies predisposing to cancer. Anticancer Res. 1990;10:513-518.
8. Shellong G. Pediatric Hodgkin's disease: treatment in the late 1990s. Ann Oncol. 1998;9:115-119.
9. Niehues T, Schellong T, Dorfell W, et al. Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies. Klin Paediatr. 2003;215: 315-320.
10. Sandoval C, Swift M. Hodgkin disease in ataxia telangiectasia patients with poor outcomes. Med Pediatr Oncol. 2003;40: 162-166.
11. Comans-Bitter WM, de Groot R, vand der Beemd R, et al. Immunophenotyping of blood lymphocytes in childhood. J Pediatr. 1997;130:388-393.
12. Sagar TG, Chandra A, Raman SG. Childhood Hodgkin's disease treated with COPP/ABVD hybrid chemotherapy: a progress report. Med Pediatr Oncol. 2003;40:66-69.
13. Desandes E, Clavel J, Berger C, et al. Cancer incidence among children in France, 1990-1999. Ped Blood Cancer. 2004;43: 749-757.
14. Michalkiewitz J, Barth C, Chrzanowska K, et al. Abnormalities in T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome. Clin Exp Immunol. 2003;134: 482-490.
15. Kondratenko I, Pashenko O, Tverskaya S, et al. Nineteen unrelated patients with Nijmegen breakage syndrome. XXth meeting of European Society for Immunodeficiencies 4-7th October, 2006, Budapest (abstract book); 167.
16. Kruger L, Demuth I, Neitzel H, et al. Cancer incidence in Nijmegen breakage syndrome is modualted by the amount of a variant NBS protein. Carcinogenesis. 2007;28:107-111.
17. Robison LL, Stoker V, Frizzera G, et al. Hodgkin's disease in pediatric patiehnts with naturally occuring immunodeficiency. Am J Pediatr Hematol Oncol. 1987;9:189-192.
18. Weyl Ben AM, Rosenthal J, Dale J, et al. Ataxia telangiectasia and lymphoma: an indication for individualized chemotherapy dosing-report of treatment in a highly inbreed Arab family. Pediatr Hematol Oncol. 1995;12:163-169.
19. Seidemann K, Henze G, Beck JD, et al. Non-Hodgkin's lymphoma in patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials. Ann Oncol. 2000;11(suppl 1):S141-S145.
20. Barth E, Demori E, Pecile V, et al. Anthracyclines in Nijmegen breakage syndrome. Med Pediatr Oncol. 2003;40:122-124.
21. Sandoval C, Swift M. Treatment of lymphoid malignancies in patients with patients with ataxia telangiectasia. Med Pediatr Oncol. 1998;31:491-497.
22. Bakhshi S, Cerosaletti KM, Concannon P, et al. Medulloblastoma with adverse reaction to radiation therapy in Nijmegen breakage syndrome. Pediatr Hematol Oncol. 2003;25: 248-251.
23. Gregorek H, Chrzanovska KH, Michalkiewitz J, et al. Heterogeneity of humoral immune abnormalities in children with Nijmegen breakage syndrome: an 8-year follow-up study in a single centre. Clin Exp Immunol. 2002;130:319-324.
24. Tullgren O, Grimfors G, Holm G, et al. Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long-term follow-up. Cancer. 1991;68:768-775.
25. Pasic S. Aplastic anemia in Nijmegen breakage syndrome. J Pediatr. 2002;141:742.